Search for: "Takeda Pharmaceuticals International"
Results 41 - 60
of 69
Sort by Relevance
|
Sort by Date
25 May 2011, 4:59 am
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US:… [read post]
29 Mar 2011, 9:19 pm
New pharmaceutical compulsory licenses proposed for patented medicines (Patentology) (ipwars) Canada: Election drum beats the life out of Access to Medicines Bill (IP Osgoode) EU opines on the patentability of human embryonic stem cells: Brüstle v Greenpeace (Kluwer Patent Blog) (IPBiz) EU: In the ECJ this week: Case C-195/09 Synthon v Merz Pharma and Case C-427/09 Generics (UK) v Synaptech (The SPC Blog) India: The production of generic drugs in India: A new trade agreement with the… [read post]
29 Sep 2010, 10:08 am
Patent No. 5,583,216 owned by Takeda Pharmaceuticals. [read post]
24 Sep 2010, 1:15 pm
Takeda Chemical Industries, Ltd. v. [read post]
9 Sep 2010, 7:09 pm
Zenith Goldline Pharmaceuticals, Inc., 471 F.3d 1369, 1377-79 (Fed. [read post]
30 May 2010, 9:45 pm
The international drugmaker Takeda agreed to change the name of a heartburn drug Kapidex after there were reports that it was being confused with a prostate cancer drug. [read post]
19 May 2010, 6:15 am
Lupin Pharmaceuticals, Inc. [read post]
13 May 2010, 4:58 pm
Comptroller-General of Patents (EPLAW) (IP Factor) (SPC blog) Duetact (Pioglitazone and Glimepiride) – US: Infringement of patent following a Paragraph IV certification: Takeda Pharmaceutical Co. [read post]
29 Apr 2010, 2:27 pm
The FDA has said it is undertaking an internal review of drug safety decision-making in addition to bringing Avandia to an advisory panel of outside experts in July. [read post]
15 Apr 2010, 4:27 am
(EPLAW) Prevacid (Lansoprazole) – US: Takeda files patent infringement complaint against Zydus following Para IV challenge (Patent Docs) Reyataz (Atazanavir) – US: Bristol-Myer Squibb, Novartis file patent infringement suit against Teva following Para IV challenge (Patent Docs) Treximet (Sumatriptan, Naproxen) – US: POZEN enters into settlement agreement with Teva regarding Para IV patent litigation (SmartBrief) Zerit (Stavudine) – US: Promote Innovation files false… [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by Bayer (Spicy… [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by Bayer (Spicy… [read post]
21 Feb 2010, 4:17 am
.), also say any head-to-head trial where patients get Avandia and Takeda Pharmaceutical Co.'s diabetes medicine Actos would be "unethical and exploitative. [read post]
26 Jan 2010, 7:06 am
Elliott ** Editor, Time International, Time Magazine, USA Panellists Dennis Nally ** Chairman, PricewaterhouseCoopers International, PricewaterhouseCoopers, USA Arif M. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
27 May 2009, 9:59 pm
" at last week's BIO International Convention, a panel consisting of Anne Dollard, the Deputy General Counsel and Chief Patent Counsel for Takeda San Francisco; Thomas Kim, Senior Director of Intellectual Property for VGX Pharmaceuticals, Inc.; Jane Gunnison of Ropes & Gray LLP; John Tessensohn of Shusaku Yamamoto Patent Law Offices; and Dr. [read post]
23 Apr 2009, 10:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Cepham – US: CAFC: Another ‘bright-line’ rule from the Federal Circuit; double jeopardy – later developments can overcome double patenting: Takeda Pharmaceutical Co v Doll (Patent Docs) (Patent Baristas) … [read post]
